{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T14:08:57Z","timestamp":1772374137703,"version":"3.50.1"},"reference-count":20,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2825,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1365-2133.2007.08269.x","type":"journal-article","created":{"date-parts":[[2010,7,22]],"date-time":"2010-07-22T09:09:32Z","timestamp":1279789772000},"page":"25-31","source":"Crossref","is-referenced-by-count":136,"special_numbering":"supplement s2","title":["Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients"],"prefix":"10.1093","volume":"157","author":[{"given":"C.","family":"Ulrich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bichel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Euvrard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Guidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.M.","family":"Proby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.C.M.","family":"Van De Kerkhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Amerio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"R\u00f8nnevig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.B.","family":"Slade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Stockfleth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2007,12,7]]},"reference":[{"key":"10.1111\/j.1365-2133.2007.08269.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM200003023420901","article-title":"Improved graft survival after renal transplantation in the United States, 1988 to 1996","volume":"342","author":"Hariharan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2007.08269.x-BIB2|cit2","first-page":"1946","article-title":"Malignancy following renal transplantation","volume":"24","author":"Sheil","year":"1992","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1365-2133.2007.08269.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1600-6143.2004.00450.x","article-title":"Cancer after kidney transplantation in the United States","volume":"4","author":"Kasiske","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1365-2133.2007.08269.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mjd.2002.125579","article-title":"Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management","volume":"47","author":"Berg","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08269.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s12094-006-0131-8","article-title":"Molecular biology in head and neck cancer","volume":"8","author":"Hitt","year":"2006","journal-title":"Clin Transl Oncol"},{"key":"10.1111\/j.1365-2133.2007.08269.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(84)92221-9","article-title":"Cancer, warts, and sunshine in renal transplant patients. A case-control study","volume":"1","author":"Boyle","year":"1984","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2007.08269.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1056\/NEJMcibr054224","article-title":"Immunosuppression, skin cancer, and ultraviolet A radiation","volume":"353","author":"Parrish","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2007.08269.x-BIB8|cit8","first-page":"1101","article-title":"Topical immunomodulation in dermatology: potential of toll-like receptor agonists","volume":"30","author":"Hengge","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1365-2133.2007.08269.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2133.2007.07942.x","article-title":"Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3\u2003days per week in one or two courses of treatment of actinic keratoses on the head","volume":"157","author":"Alomar","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08269.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jaad.2007.01.047","article-title":"Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3\u2003days per week in one or two courses of treatment for actinic keratoses on the head","volume":"57","author":"Jorizzo","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08269.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1001\/archderm.140.12.1542-a","article-title":"Low incidence of new actinic keratoses after topical 5% imiquimod cream treatment: a long-term follow-up study","volume":"140","author":"Stockfleth","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08269.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2230.2004.01601.x","article-title":"Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma","volume":"29","author":"Vidal","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08269.x-BIB13|cit13","first-page":"44","article-title":"Aggressive undifferentiated squamous cell carcinoma in an immunosuppressed patient after kidney transplantation","volume":"3","author":"Haustein","year":"2005","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/j.1365-2133.2007.08269.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/01.TP.0000113445.02908.06","article-title":"Treatment of Bowen\u2019s disease with imiquimod 5% cream in transplant recipients","volume":"77","author":"Prinz","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1365-2133.2007.08269.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/archderm.141.8.985","article-title":"Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial","volume":"141","author":"Brown","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08269.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2133.2005.06322.x","article-title":"Imiquimod cream 5% for recalcitrant cutaneous warts in immunosuppressed individuals","volume":"152","author":"Harwood","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08269.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1258\/09564620260079680","article-title":"Topical imiquimod cream 5% for resistant perianal warts in a renal transplant patient","volume":"13","author":"Gayed","year":"2002","journal-title":"Int J STD AIDS"},{"key":"10.1111\/j.1365-2133.2007.08269.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1046\/j.0366-077X.2003.05627.x","article-title":"Viral warts in organ transplant recipients: new aspects in therapy","volume":"149","author":"Schmook","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08269.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMra022137","article-title":"Skin cancers after organ transplantation","volume":"24","author":"Euvrad","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2007.08269.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2133.2006.07233.x","article-title":"Successful treatment of multiple actinic keratoses in organ transplant patients with topical 5% imiquimod: a report of six cases","volume":"155","author":"Ulrich","year":"2006","journal-title":"Br J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2007.08269.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2007.08269.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:23:12Z","timestamp":1676384592000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/157\/s2\/25\/6640756"}},"subtitle":["Topical immunomodulation under systemic immunosuppression"],"short-title":[],"issued":{"date-parts":[[2007,12,7]]},"references-count":20,"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08269.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,7]]}}}